MedPath

河南润弘制药股份有限公司

Ownership
-
Established
2002-06-26
Employees
-
Market Cap
-
Website
www.runhong-pharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

154

NMPA:154

Drug Approvals

Flumazenil Injection

Product Name
氟马西尼注射液
Approval Number
国药准字H20254517
Approval Date
Jun 10, 2025
NMPA

Peramivir Injection

Product Name
帕拉米韦注射液
Approval Number
国药准字H20254354
Approval Date
May 27, 2025
NMPA

Tirofiban Hydrochloride and Sodium Chloride Injection

Product Name
盐酸替罗非班氯化钠注射液
Approval Number
国药准字H20249445
Approval Date
Nov 22, 2024
NMPA

Tirofiban Hydrochloride and Sodium Chloride Injection

Product Name
盐酸替罗非班氯化钠注射液
Approval Number
国药准字H20249446
Approval Date
Nov 22, 2024
NMPA

Urapidil Hydrochloride Injection

Product Name
盐酸乌拉地尔注射液
Approval Number
国药准字H20244937
Approval Date
Sep 19, 2024
NMPA

Urapidil Hydrochloride Injection

Product Name
盐酸乌拉地尔注射液
Approval Number
国药准字H20244938
Approval Date
Sep 19, 2024
NMPA

Tranexamic Acid Injection

Product Name
氨甲环酸注射液
Approval Number
国药准字H20244340
Approval Date
Jun 28, 2024
NMPA

Tranexamic Acid Injection

Product Name
氨甲环酸注射液
Approval Number
国药准字H20244339
Approval Date
Jun 28, 2024
NMPA

Nitroglycerin Injection

Product Name
硝酸甘油注射液
Approval Number
国药准字H20247124
Approval Date
Jun 12, 2024
NMPA

Aminophylline Injection

Product Name
氨茶碱注射液
Approval Number
国药准字H20237185
Approval Date
Dec 28, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.